H.C. Wainwright has downgraded Syros Pharmaceuticals (NASDAQ:SYRS) to neutral from buy, citing Tuesday’s announcement that a ...

H.C. Wainwright raised the firm’s price target on Perpetua Resources (PPTA) to $22 from $13.25 and keeps a Buy rating on the shares ...

Ardelyx (NASDAQ:ARDX) shares were down over 5% after H.C. Wainwright downgraded the rating for the biopharmaceutical firm, ...

H.C. Wainwright raised the firm’s price target on electroCore (ECOR) to $22 from $15 and keeps a Buy rating on the shares after the firm ...

We recently compiled a list of the 15 AI News That Should Not Be Ignored. In this article, we are going to take a look at ...

WidePoint Corporation (AMEX: WYY) Q3 2024 Earnings Call Transcript November 13, 2024 ...

H.C. Wainwright downgraded Syros Pharmaceuticals (SYRS) to Neutral from Buy with a price target of $1, down from $6, after ...

On Thursday, SpringWorks Therapeutics Inc (SWTX) stock saw a modest uptick, ending the day at $36.55 which represents a slight increase of $1.84 or 5.30% from the prior close of $34.71. The stock ...

On Thursday, OPKO Health Inc (OPK) stock saw a modest uptick, ending the day at $1.62 which represents a slight increase of $0.02 or 1.25% from the prior close of $1.6. The stock opened at $1.58 and ...

Phunware (NASDAQ:PHUN) shares retreated 11% in Tuesday late morning trading after H.C. Wainwright & Co. downgraded the application software company to Neutral from Buy, as analyst Scott Buck became ...

Ardelyx (NASDAQ:ARDX) shares were down over 5% after H.C. Wainwright downgraded the rating for the biopharmaceutical firm, saying that it anticipates a substantial drop in the company's kidney ...

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.